Dataset from Immunogenicity, Reactogenicity and Safety Study of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) When Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00007516
下载链接
链接失效反馈官方服务：
资源简介：
MenACWY (Menveo) is a GSK vaccine intended for protection against disease caused by
meningococcal bacteria groups A, C, W and Y in infants, children and adults, licensed in more
than 60 countries.
The purpose of this study is to compare the immunogenicity of the currently licensed MenACWY
vaccine with the investigational MenACWY liquid vaccine aged for different lengths of time by
storage at 2-8ºC.
创建时间：
2024-11-27
